Emalex Biosciences
Biotechnology ResearchIllinois, United States11-50 Employees
Emalex Biosciences is in late-stage development for a new class of drug for patients with Tourette syndrome and other neurological disorders.
Emalex Biosciences uses 8 technology products and services including Site Kit, MySQL, Microsoft Dynamics, and more. Explore Emalex Biosciences's tech stack below.
| Emalex Biosciences Email Formats | Percentage |
| FLast@emalexbiosciences.com | 91% |
| First_Last@emalexbiosciences.com | 3% |
| First-Last@emalexbiosciences.com | 4% |
| First@emalexbiosciences.com | 2% |
Biotechnology ResearchIllinois, United States11-50 Employees
Emalex Biosciences is in late-stage development for a new class of drug for patients with Tourette syndrome and other neurological disorders.
Emalex Biosciences has raised a total of $270M of funding over 3 rounds. Their latest funding round was raised on Nov 03, 2022 in the amount of $270M.
Emalex Biosciences's revenue is estimated to be in the range of $10M$25M
Emalex Biosciences has raised a total of $270M of funding over 3 rounds. Their latest funding round was raised on Nov 03, 2022 in the amount of $270M.
Emalex Biosciences's revenue is estimated to be in the range of $10M$25M